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a b s t r a c t
Two new complexes of platinum(II) and silver(I) with acesulfame were synthesized. Acesulfame is in the
anionic form acesulfamate (ace). The structures of both complexes were determined by X-ray crystallog-
raphy. For K2[PtCl2(ace)2] the platinum atom is coordinated to two Cl and two N-acesulfamate atoms
forming a trans-square planar geometry. Each K+ ion interacts with two oxygen atoms of the S(@O)2
group of each acesulfamate. For the polymeric complex [Ag(ace)]n the water molecule bridges between
two crystallographic equivalent Ag1 atoms which are related each other by a twofold symmetry axis.
Two Ag1 atoms, related to each other by a symmetry centre, make bond contact with two equivalent oxy-
gen atoms. These bonds give rise to inﬁnite chains along the unit cell diagonal in the ac plane. The in vitro
cytotoxic analyses for the platinum complex using HeLa (human cervix cancer) cells show its low activity
when compared to the vehicle-treated cells. The Ag(I) complex submitted to in vitro antimycobacterial
tests, using the Microplate Alamar Blue (MABA) method, showed a good activity against Mycobacterium
tuberculosis, responsible for tuberculosis, with a minimal inhibitory concentration (MIC) value of
11.6 lM. The Ag(I) complex also presented a promising activity against Gram negative (Escherichia coli
and Pseudomonas aeruginosa) and Gram positive (Enterococcus faecalis) microorganisms. The complex
K2[PtCl2(ace)2] was also evaluated for antiviral properties against dengue virus type 2 (New Guinea C
strain) in Vero cells and showed a good inhibition of dengue virus type 2 (New Guinea C strain) replication
at 200 lM, when compared to vehicle-treated cells.
 2010 Elsevier Inc. All rights reserved.
1. Introduction
Over the years there has been a continuous interest in the
chemistry of metal complexes with biological activity, including
platinum complexes with antitumoral activity and silver com-
plexes with antimicrobial action. The complex cis-[PtCl2(NH3)2]
(cis-DDP or cisplatin) [1], and carboplatin are the most widely used
platinum anticancer drugs. The ultimate target for platinum anti-
tumor drugs is the DNA molecule by forming Pt-1,2-d(GpG)
(65%) and Pt-1,2-d(ApG) (25%) intrastrand cross-links which are
the critical lesions that led to the cytotoxic activity [2,3]. The
formation of these adducts blocks the replication of the malignant
tumor cells and inhibits cancer growth [4,5]. However, the clinical
success of cisplatin is limited by the signiﬁcative side effects
and acquired or intrinsic resistance, which in turns strengths
the need for new platinum drugs. Some strategies have been ap-
plied for the design of new drugs, such as the use of other types
of ligands, in order to reduce side effects and increase the
antitumoral effect of the drug. Much attention has also been fo-
cused on synthesis of new dinuclear or trinuclear species, like
the compound [trans-PtCl(NH3)2)2(l-trans-Pt-(NH3)2(NH2(CH2)6-
NH2)2)](NO3)4 (BBR3464) which is in Phase II clinical trial and
showed consistent activity against cisplatin-resistant human
tumors [6,7].
Silver and several of its compounds have also been used in Med-
icine as antimicrobial agents [8–14] and showed to be effective
against different pathogens (bacteria, viruses, and eukaryotic
microorganisms) [8]. Silver(I) sulfadiazine has been used clinically
as an antibacterial and antifungical agent since 1947. It is an insoluble
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polymeric compound that releases Ag(I) ions slowly and is applied
topically as a cream to prevent bacterial infections in cases of se-
vere burns [11,15]. The mechanism of antimicrobial activity of
Ag(I) complexes has been scarcely reported, although three possi-
ble mechanisms for inhibition of bacteria growing by aqueous Ag(I)
ions was proposed: (i) interference with the electron transport sys-
tem; (ii) DNA-binding; and (iii) interaction with the cell membrane
[13,16]. Nomiya and co-workers [13,17,18] suggested that Ag(I)
complexes with good leaving groups, especially those containing
N/O donor atoms, are able to target some bacterial proteins which
possess S containing ligands in their active sites. The molecules
containing N/O donor atoms are easily replaced in the silver coor-
dination sphere by S-ligands found in the bacterial proteins active
sites. It was suggested that this mechanism is responsible for a
wide spectrum of antimicrobial activities.
Among target microorganisms sensitive to silver complexes,
Mycobaterium tuberculosis, responsible for tuberculosis, is one of
the most important. Tuberculosis still remains a remarkable world-
wide public health problem. According to the WHO Report 2007
there were about 8.8 million new tuberculosis cases in the world
in 2005. A total of 1.6 million people died of tuberculosis, including
190,000 patients infected with HIV [19]. Despite the discovery of
new drugs and the improvement of tuberculosis treatment, such
disease is severely affected by the development of multi-drug
resistant M. tuberculosis strains [20,21].
Considering the importance of the discovery of new platinum
and silver complexes [22,23] with biological activity, two plati-
num(II) and silver(I) complexes with the ligand acesulfame-K, a
widespread commercial sweetener (see Fig. 1), are described in
the present article. Acesulfame is in the form of the anionic ligand
acesulfamate (ace). It has low toxicity at low concentrations and
could reduce the toxicity of the complexes for the human body
or even decrease the side effects in comparison to the common
used drugs. The two solid complexes were ﬁrst characterized by
IR spectroscopy and thermogravimetric analysis, and have their
crystal structure determined. The antibacterial activity of the
Ag(I) complex and the antitumoral activity of the platinum(II)
complex were also evaluated.
2. Experimental
2.1. Materials
Acesulfame-K was purchased from Monsanto (Brazil), potas-
sium tetrachloroplatinate(II) is an analytical grade product from
Sigma, and silver(I) nitrate was purchased from Acros Organics.
All other chemicals are analytical grade products from different
sources.
2.2. Instrumental methods
Elemental analyses of carbon, hydrogen and nitrogen were per-
formed using a CHNS-O EA1110 CE Instruments analyzer: High
purity cysteine was used as a reference substance. Silver content
was determined by atomic absorption using a Perkin Elmer instru-
ment. Infrared spectra were recorded on a Spectrum 2000 FT-IR
Perkin Elmer spectrophotometer, using samples prepared as KBr
pellets. Thermal analysis was performed on a Thermoanalyzer
TG/DTA simultaneous SDT 2960 TA Instruments under the follow-
ing conditions: aluminum crucible, synthetic air (100 mL/min), and
heating at 10 C per minute, from 30 to 1000 C. Powder X-ray dif-
fraction measurements of the thermodecomposition residues at
1000 C were performed on a Siemens D5000 Kristalloﬂex diffrac-
tometer, Cu Ka radiation, Ni-ﬁlter. Powder X-ray diffractograms
were compared to standard diffractograms deposited in the ICDD
X-ray data base (International Centre of Diffraction Data). The
powder X-ray diffraction technique was only used to identify the
ﬁnal residues of the thermogravimetric analyses.
2.3. Synthesis of the K2[PtCl2(ace)2] complex
An aqueous solution of K2[PtCl4] (3.6  104 mol, 25 mL) was
added to a solution containing 6.9  104 mol of acesulfame-K
(25 mL) under stirring. After several days of slow evaporation at
room temperature, yellow needle-like crystals suitable for single-
crystal diffraction studies were obtained. In this case, yield was
not determined. Calc.% for C8H8K2PtN2S2O8: C, 14.4; H, 1.21; N,
4.19; S, 9.59; K, 11.7; Found: C, 13.5; H, 1.47; N, 4.13; S, 10.2; K,
12.5. (Although the elemental analysis data for C and K are some-
what unsatisfactory, the crystal structure determination in this
work for the complex conﬁrmed the formula.)
2.4. Synthesis of the [Ag(ace)]n complex
An aqueous solution of AgNO3 (2.0  103 mol, 25 mL) was
slowly added to a solution containing 2.0  103 mol of acesul-
fame-K in 25 mL of H2O under stirring. After 2 days of standing
at room temperature, white crystals suitable for single-crystal dif-
fraction studies were obtained. Yield: 76%. The crystals of the com-
plex were washed with 200 mL of water and dried at room
temperature. Calc.% for C4H4AgO4NS: C, 17.8; H, 1.49; N, 5.19;
Found.: C, 17.5; H, 1.54; N, 5.05.
2.5. X-ray data collection and structure determination
A white prismatic crystal of dimensions 0.262  0.240 
0.135 mm3 of [Ag(ace)]n and a yellow prismatic crystal of dimen-
sions 0.15  0.08  0.07 mm3 of K2[PtCl2(ace)2] were selected and
an Enraf–Nonius Kappa-CCD diffractometer with a graphite mono-
chromated Mo Ka (k = 0.71073 Å) radiation was used for data col-
lection. Data were collected up to 52 in 2h and ﬁnal unit cell
parameters were based on all reﬂections. The temperature was
controlled using an Oxford Cryosystem low temperature device,
operating at 120 K. Data collection was carried out using the COL-
LECT program [24]. Integration and scaling of the reﬂections were
performed with the HKL Denzo–Scalepack system of programs [25]
and numerical absorption corrections were performed [26]. The
structure was solved using direct methods with SHELXS-97 [27].
The model was reﬁned by full-matrix least-squares on F2 by means
of SHELXL-97 [28]. All hydrogen atoms were located on stereo-
chemical grounds and reﬁned with the riding model. Hydrogen
atoms were set isotropic with a thermal parameter 20% greater
than the equivalent isotropic displacement parameter of the car-
bon to which each one is bonded; this percentage was set to 50%
for the hydrogen atoms of the methyl groups.
2.6. Cytotoxicity evaluation
2.6.1. Cell culture
The culture of the HeLa (human cervix cancer) cells was per-
formed at 37 C in a humidiﬁed atmosphere containing 5% of
N-
SO
CH3
O
O
O
K+
Fig. 1. Scheme of acesulfame-K.
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CO2. Cells were grown in DMEM supplemented with 10% of FCS, at
pH 7.4. Gentamicin (10 lg/mL) was used as an antibiotic.
2.6.2. Cell viability assays
At the ﬁrst day, cells were detached and plated in a 48-well
plate (2  104 cells/well). The medium was exchanged after 24 h
and aqueous solutions of the complex in different concentrations,
or the vehicle, were added. The mixture was then incubated for a
48 h period. After this period, 50 lL of a MTT [29] solution
(5 mg/mL in PBS) were added to each well and the cells were incu-
bated for additional 3 h. After that, the medium was removed, the
cells were washed with PBS, and 200 lL of isopropanol-HCl
(0.040 mol/L) were added. Cell viability was directly correlated to
the determined absorbance values obtained by measurements at
570 nm. Values obtained for the vehicle-treated cells were used
as the reference for 100% of viability.
2.7. Antimycobacterial assay
2.7.1. Standard drugs and the silver(I) complex
Stock solutions of isoniazid and silver(I)-sulfadiazine, from Sig-
ma (10 mg/mL) and aqueous solutions of the Ag(I) complex were
diluted in 7H9 broth to obtain the ﬁnal concentration.
2.7.2. Mycobacterial strains: M. tuberculosis
ATCC 27294 used for antimycobacterial activity analysis was
maintained in a Lowenstein-Jensen medium. Each culture suspen-
sion was prepared by subculturing in Middlebrook 7H9 broth (Dif-
co) supplemented with 10% OADC (BBL™) at 37 C, until a density
corresponding to a McFarland standard no. 1 was obtained (about
7–10 days).
2.7.3. Microplate Alamar Blue assay (MABA)
Antimycobacterial activities of the silver(I)–acesulfame com-
plex and isoniazid were determined in triplicate using sterile 96-
well plates (Falcon 3072; Becton Dickinson, Lincoln Park, NJ). The
minimal inhibitory concentration (MIC) of these drugs necessary
to inhibit 90% of the mycobacterial grow-up using the MABAmeth-
od was measured [30]. The visual MIC value was deﬁned as the
lowest drug concentration that prevented a color change of the
Alamar Blue reagent (Accumed International, Westlake, Ohio) from
blue to pink. A blue color in the well was interpreted as the ab-
sence of growing and a pink color was considered as mycobacteria
growing.
2.8. Antibacterial assay
Four referenced bacteria (Staphylococcus aureus – ATCC 25923,
Pseudomonas aeruginosa ATCC – 27853, Escherichia coli – ATCC
25922 and Enterococcus faecalis – ATCC 29212) were used in the
present study. An antibiogram assay was performed by the disc dif-
fusion method [31,32]. The sensitivity of the complexes Ag–ace
and Pt–ace was tested using Mueller–Hinton (MH) agar plates.
The microorganisms (E. coli, S. aureus, P. aeruginosa and E. faecal-
is) were transferred to separate test tubes containing 5.0 mL of a
sterile BHI medium and incubated for 18 h at 35–37 C. Sufﬁcient
inoculums were added in new tubes until the turbidity equaled
to 0.5 McFarland (108 CFU/mL). The bacterial inoculums diluted
with BHI (McFarland standard) were uniformly spread using sterile
cotton swabs on sterile Petri dishes MH agar.
Sterile ﬁlter paper discs of 10 mm in diameter were aseptically
impregnated with the complexes Ag–ace and Pt–ace. Sterile discs
impregnated with AgNO3 were used as a positive control [33,34],
while discs with free acessulfame-K and dimethyl sulfoxide were
used as a negative control. All impregnated discs were allowed to
stand until complete solvent evaporation and placed on the surface
of solid agar. The plates were incubated for 18 h at 35–37 C and
examined thereafter. Clear zones of inhibition formed around the
discs were measured and the complexes sensitivity was assayed
from the diameter of the clear inhibition zones (in mm).
2.9. Antiviral assays
The antiviral assays were performed using a Vero cell line orig-
inated from monkey kidney cells and are permissive to dengue
virus infections [35]. Cell monolayers were infected with dengue
virus type 2 (New Guinea C strain). Vero cells were plated at
1  105 cells/well density in 24-well plates and maintained at
37 C for 24 h in the culture medium DMEM (Invitrogen, Grand Is-
land, New York) supplemented with 5% fetal bovine serum (Invit-
rogen, Grand Island, New York). After this step, infected cell
supernatants were removed and the cell monolayers were washed
with 1  PBS buffer. Dengue infections were performed at a multi-
plicity of infection (MOI) of 1 (1 virus for each cell) during 1 h at
37 C. The antiviral experiment group consisted of infected cells
treated with 2 lM, 20 lM or 200 lM solutions of the Pt–ace com-
plex. The infected cells were washed with 1  PBS and then cov-
ered with DMEM medium supplemented with 5% FBS. The cell
supernatants were collected daily from duplicate wells to evaluate
the replication proﬁle of dengue virus type 2 in infected Vero cells
(control group), and in the treatment group, where dengue type 2
infected cells were incubated with different concentrations of the
Pt–ace complex.
2.9.1. Real-time quantitative reverse transcription-polymearase chain
reaction (RT-PCR)
Viral RNA was extracted from the supernatant using a QIAamp
viral RNA kit, and the absolute quantiﬁcation of virus replication
was done on the infected cell supernatants by real-time RT-PCR
using a Sybr Green protocol (Applied Biosystems). Primers and
general conditions for real-time PCR reactions were the same as
those described by Houng et al. [36].
3. Results and discussion
3.1. Structure description
Yellow crystals of the Pt–ace complex were analyzed by X-ray
diffraction. Experimental details of the X-ray data collection pre-
sented in Table 1 shows that the compound crystallizes in the
monoclinic P21/c space group. ORTEP [37] projections of the struc-
ture of the complex are shown in Fig. 2 and relevant data are sum-
marized in Tables 2 and 3.
The platinum atom is coordinated to two Cl ions and two N-
acesulfamate atoms forming a trans-square planar geometry. Each
potassium atom interacts with two oxygen atoms of the S(@O)2
group of each acesulfamate. The Pt–N(1) and Pt–N(1)#1 distances
are identical [2.036(3) Å] and the Pt–Cl and Pt–Cl#1 distances are
both equal to 2.3007(10) Å. The Pt–N bond length of the complex
is slightly shorter than that of the platinum-saccharinate complex
[PtCl(sac)(PPh3)3] described in the literature [Pt–N = 2.064(6) Å]
but it is slightly longer than those of the dinuclear platinum-sac-
charinate complex {K[Pt(sac)3(H2O)]H2O}2 obtained in our labora-
tories [Pt(1)–N(3), Pt(1)–N(2) and Pt(1)–N(1) equal to 2.014(4) Å,
1.983(5) Å and 2.019(4) Å, respectively] [22].
White crystals of the Ag–ace complex were mechanically sepa-
rated and analyzed by X-ray crystallography. Experimental details
of the X-ray data collection reported in Table 4 show that the com-
pound crystallizes in the monoclinic P2/n space group. ORTEP pro-
jections of the structure of the Ag–ace complex are shown in Fig. 3
and relevant data are summarized in Tables 5 and 6.
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The water molecule bridges between two crystallographic
equivalent Ag1 atoms which are related each other by a twofold
symmetry axis [Ag1–O1w = 2.487(2) Å]. Two Ag1 atoms, related
each other by a symmetry centre, are bonded to equivalent oxygen
atoms O211 [Ag1–O21 = 2.586(2) Å]. These interactions give rise to
inﬁnite chains along the unit cell diagonal in the ac plane.
3.2. Spectroscopic data
Main IR features of acesulfame-K are: m (C@O) at 1662 cm1;
symmetric axial deformation of S(@O)2 group at 1365 cm1; m
(C–N) at 1296 cm1; assymmetric axial deformation of S(@O)2
group at 1180 cm1; axial deformation of the S–O–C system at
1077 cm1, 1016 cm1, 943 cm1 and 839 cm1. Changes of the
Table 1
Crystallographic data collection and structure reﬁnement of the Pt–ace complex.
Empirical formula C8H8K2N2O8PtS2
fw 668.47
Temperature 296(2) K
Wavelength 0.71073 Å
Crystal system, space group Monoclinic, P21/c
a (Å) 8.8800(3)
b (Å) 9.2770(5)
c (Å) 11.5184(5)
b (deg) 99.036(3)
V (Å3) 937.11(7)
Z 2
Dcalcd (Mg/m3) 2.369
Abs. coeff. (mm1) 8.476
F(0 0 0) 632
Crystal size (mm) 0.15  0.08  0.07
Theta range for data collection
(deg)
3.20–26.00
Limiting indices 10 6 h 6 10, 11 6 k 6 10,
14 6 l 6 14
Reﬂections collected/unique 4845/1829 [R(int) = 0.0245]
Completeness to theta = 25.00 99.8%
Absorption correction Numerical
Max. and min. transmission 0.5766 and 0.3688
Reﬁnement method Full-matrix least-squares on F2
Data/restraints/parameters 1829/0/116
Goodness-of-ﬁt on F2 1.110
Final R indices [I > 2r(I)] R1 = 0.0235, wR2 = 0.0552
R indices (all data) R1 = 0.0288, wR2 = 0.0577
Largest diff. peak and hole (e Å3) 0.880 and 1.265
Fig. 2. ORTEP view of the Pt(II)–acesulfame molecule with atom labeling. Proba-
bility ellipsoids are 30%. Water hydrogen atoms are not included in the drawing.
Table 2
Selected bond lengths (Å) of the Pt–ace complex.
Pt–N(1) 2.036(3) K–K#2 4.8336(6)
Pt–N(1)#1 2.036(3) Cl–K#6 3.1289(16)
Pt–Cl#1 2.3007(10) Cl–K#3 3.1674(16)
Pt–Cl 2.3007(10) S–O(12) 1.424(3)
Pt–K#2 3.5765(10) S–O(11) 1.430(3)
Pt–K#3 3.5766(10) S–O(1) 1.584(3)
K–O(2)#4 2.680(4) S–N(1) 1.596(3)
K–O(12)#5 2.747(3) O(1)–C(3) 1.404(6)
K–O(11)#6 2.782(3) O(2)–C(1) 1.219(5)
K–O(11) 2.923(3) O(2)–K#3 2.680(4)
K–Cl#6 3.1289(16) O(11)–K#6 2.782(3)
K–O(12) 3.153(4) O(12)–K#2 2.747(3)
K–Cl#4 3.1674(16) N(1)–C(1) 1.385(5)
K–S 3.5342(15) C(1)–C(2) 1.466(6)
K–Pt#5 3.5765(10) C(2)–C(3) 1.320(6)
K–K#6 4.508(2) C(3)–C(4) 1.485(6)
K–K#5 4.8336(6)
Table 3
Selected angles (deg) of the Pt–ace complex.
N(1)–Pt–N(1)#1 180.0 O(12)–K–K#6 76.73(7)
N(1)–Pt–Cl#1 88.36(10) Cl#4–K–K#6 123.40(5)
N(1)#1–Pt–Cl#1 91.64(10) S–K–K#6 57.02(3)
N(1)–Pt–Cl 91.64(10) Pt#5–K–K#6 161.57(5)
N(1)#1–Pt–Cl 88.36(10) O(2)#4–K–K#5 93.19(7)
Cl#1–Pt–Cl 180.0 O(12)#5–K–K#5 37.86(8)
N(1)–Pt–K#2 95.09(9) O(11)#6–K–K#5 89.15(7)
N(1)#1–Pt–K#2 84.91(9) O(11)–K–K#5 135.17(8)
Cl#1–Pt–K#2 60.71(3) Cl#6–K–K#5 40.15(2)
Cl–Pt–K#2 119.29(3) O(12)–K–K#5 157.54(7)
N(1)–Pt–K#3 84.91(9) Cl#4–K–K#5 110.15(4)
N(1)#1–Pt–K#3 95.09(9) S–K–K#5 150.35(4)
Cl#1–Pt–K#3 119.29(3) Pt#5–K–K#5 80.68(3)
Cl–Pt–K#3 60.71(3) K#6–K–K#5 116.79(4)
K#2–Pt–K#3 180.0 O(2)#4–K–K#2 74.47(7)
O(2)#4–K–O(12)#5 103.66(11) O(12)#5–K–K#2 114.86(8)
O(2)#4–K–O(11)#6 156.86(11) O(11)#6–K–K#2 114.13(8)
O(12)#5–K–O(11)#6 92.24(10) O(11)–K–K#2 75.27(7)
O(2)#4–K–O(11) 86.68(10) Cl#6–K–K#2 162.14(5)
O(12)#5–K–O(11) 166.95(10) O(12)–K–K#2 32.33(6)
O(11)#6–K–O(11) 75.62(10) Cl#4–K–K#2 39.56(3)
O(2)#4–K–Cl#6 90.24(7) S–K–K#2 54.53(2)
O(12)#5–K–Cl#6 77.23(8) Pt#5–K–K#2 66.99(3)
O(11)#6–K–Cl#6 76.83(7) K#6–K–K#2 95.01(3)
O(11)–K–Cl#6 95.04(7) K#5–K–K#2 147.33(5)
O(2)#4–K–O(12) 64.46(9) Pt–Cl–K#6 121.65(4)
O(12)#5–K–O(12) 145.41(8) Pt–Cl–K#3 79.99(4)
O(11)#6–K–O(12) 110.49(9) K#6–Cl–K#3 100.29(3)
O(11)–K–O(12) 46.60(9) O(12)–S–O(11) 115.5(2)
Cl#6–K–O(12) 132.02(7) O(12)–S–O(1) 105.50(18)
O(2)#4–K–Cl#4 83.39(8) O(11)–S–O(1) 107.04(18)
O(12)#5–K–Cl#4 75.30(7) O(12)–S–N(1) 111.07(19)
O(11)#6–K–Cl#4 117.32(8) O(11)–S–N(1) 112.67(18)
O(11)–K–Cl#4 114.34(8) O(1)–S–N(1) 104.10(17)
Cl#6–K–Cl#4 149.39(5) O(12)–S–K 62.95(16)
O(12)–K–Cl#4 71.20(6) O(11)–S–K 53.65(14)
O(2)#4–K–S 72.26(8) O(1)–S–K 111.42(12)
O(12)#5–K–S 169.12(8) N(1)–S–K 144.30(12)
O(11)#6–K–S 94.80(7) C(3)–O(1)–S 117.3(3)
O(11)–K–S 23.20(7) C(1)–O(2)–K#3 129.8(3)
Cl#6–K–S 112.47(4) S–O(11)–K#6 135.58(18)
O(12)–K–S 23.71(6) S–O(11)–K 103.14(17)
Cl#4–K–S 94.07(4) K#6–O(11)–K 104.38(10)
O(2)#4–K–Pt#5 58.83(8) S–O(12)–K#2 145.58(19)
O(12)#5–K–Pt#5 59.18(7) S–O(12)–K 93.33(18)
O(11)#6–K–Pt#5 144.02(8) K#2–O(12)–K 109.82(10)
O(11)–K–Pt#5 133.86(7) C(1)–N(1)–S 120.3(3)
Cl#6–K–Pt#5 113.12(4) C(1)–N(1)–Pt 122.5(3)
O(12)–K–Pt#5 88.75(6) S–N(1)–Pt 116.75(17)
Cl#4–K–Pt#5 39.31(2) O(2)–C(1)–N(1) 120.5(4)
S–K–Pt#5 110.98(3) O(2)–C(1)–C(2) 122.6(4)
O(2)#4–K–K#6 122.00(9) N(1)–C(1)–C(2) 116.8(4)
O(12)#5–K–K#6 130.98(8) C(3)–C(2)–C(1) 124.2(4)
O(11)#6–K–K#6 38.91(7) C(2)–C(3)–O(1) 120.1(4)
O(11)–K–K#6 36.71(6) C(2)–C(3)–C(4) 129.2(4)
Cl#6–K–K#6 85.20(4) O(1)–C(3)–C(4) 110.6(4)
536 M. Cavicchioli et al. / Journal of Inorganic Biochemistry 104 (2010) 533–540
S(@O)2 group vibrational frequencies in the IR spectrum of the
Pt–ace complex are observed at 1329 cm1 and 1175 cm1 due
to the interaction of the oxygen atom to K+. The trans Pt–ace com-
plex (D2h) exhibits only one band assigned to the Pt–Cl stretching
frequency at 330 cm1. The band at 217 cm1 is assigned to the
Pt–N stretching vibrational mode. This band was also observed
in the IR spectra of some metal-pyridine complexes [38]. No
signiﬁcant changes in the IR spectrum of the Ag–ace complex
when compared to the IR spectrum of the acesulfame-K were
observed.
3.3. Thermogravimetric measurements
Thermogravimetric analysis of K2[PtCl2(ace)2] shows a net
weight loss of about 62.5%, consistent with the ﬁnal formation of
platinum(0) and potassium sulfate. Powder X-ray diffractogram
of the residue at 1200 C conﬁrms the formation of metallic Pt
and K2SO4. Fig. 4 shows the thermogravimetric curve of the com-
plex and the powder X-ray diffractogram of the residue, at 650 C
and 1200 C, which matches with the reﬂections related to plati-
num(0) and potassium sulfate, respectively [39,40]. The residue
at 650 C indicates the formation of platinum(0) while the residue
at 1200 C indicates the formation of platinum(0) and potassium
sulfate. So, at 650 C the ligands were released from the metal,
but they were not completely decomposed, The complete decom-
position of the ligand and formation of potassium sulfate occurs
at 1200 C.
Thermogravimetric analysis of [Ag(ace)]n shows a net weight
loss of 65.1%, consistent with the ﬁnal formation of silver(0).
Table 4
Crystallographic data collection and structure reﬁnement of the Ag–ace complex.
Empirical formula C16H16Ag4N4O17S4
fw 1096.031
Temperature 296(2) K
Wavelength 0.71073 Å
Crystal system, space group Monoclinic, P2/n
a (Å) 13.5030(3)
b (Å) 7.5640(1)
c (Å) 15.1390(3)
b (deg) 113.1230(1)
V (Å3) 1422.03(5)
Z 2
Dcalcd (Mg/m3) 2.56
Abs. coeff. (mm1) 3.093
F(0 0 0) 1056
Crystal size (mm) 0.262  0.240  0.135
Theta range for data collection (deg) 2.59–25.99
Limiting indices 16 6 h 6 16, 9 6 k 6 9,
18 6 l 6 18
Reﬂections collected/independent
reﬂections
13,407/2774 [R(int) = 0.0283]
Completeness to theta = 25.00 99.1%
Absorption correction Gaussian
Max. and min. transmission 0.6717 and 0.4908
Reﬁnement method Full-matrix least-squares on F2
Data/restraints/parameters 2774/0/207
Goodness-of-ﬁt on F2 1.126
Final R indices [I > 2r(I)] R1 = 0.0244, wR2 = 0.0613
R indices (all data) R1 = 0.0273, wR2 = 0.0625
Largest diff. peak and hole (e Å3) 0.596 and 0.659
Fig. 3. ORTEP view of the Ag(I)–acesulfame molecule with atom labeling. Probability ellipsoids are 30%. Water hydrogen atoms are not included in the drawing.
Table 5
Selected bond lengths (Å) of the Ag–ace complex.
Ag(2)–O(12) 2.140(2) C(11)–C(13) 1.333(4)
Ag(2)–O(22) 2.143(2) C(11)–C(12) 1.486(4)
Ag(2)–O(211)#1 2.518(2) C(12)–H(12A) 0.9600
Ag(2)–Ag(1) 2.8534(3) C(12)–H(12B) 0.9600
Ag(1)–N(2) 2.256(2) C(12)–H(12C) 0.9600
Ag(1)–N(1) 2.260(2) C(13)–C(14) 1.453(4)
Ag(1)–O(1W) 2.492(2) C(13)–H(13) 0.9300
Ag(1)–O(212)#2 2.586(2) C(23)–C(21) 1.333(4)
S(1)–O(111) 1.417(2) C(23)–C(24) 1.445(4)
S(1)–O(112) 1.423(2) C(23)–H(23) 0.9300
S(1)–N(1) 1.604(2) O(21)–C(21) 1.390(3)
S(1)–O(11) 1.625(2) O(21)–S(2) 1.610(2)
O(1W)–Ag(1)#3 2.492(2) C(21)–C(22) 1.482(4)
O(1W)–H(1W) 0.81(6) C(22)–H(22A) 0.9600
O(11)–C(11) 1.385(4) C(22)–H(22B) 0.9600
O(12)–C(14) 1.248(3) C(22)–H(22C) 0.9600
O(22)–C(24) 1.250(3) S(2)–O(212) 1.421(2)
N(1)–C(14) 1.361(3) S(2)–O(211) 1.423(2)
N(2)–C(24) 1.360(3) O(211)–Ag(2)#4 2.517(2)
N(2)–S(2) 1.603(2) O(212)–Ag(1)#2 2.586(2)
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Powder X-ray diffraction of the residue at 750 C conﬁrms the for-
mation of Ag. Fig. 5 shows the thermogravimetric curve of [Ag(a-
ce)]n and the corresponding powder X-ray diffractogram of its
residue at 750 C, which matches with the reﬂections related to
Ag(0) [41]. The ﬁrst mass loss in the temperature range 40–
580 C is related to the loss of the ligands.
3.4. Cytotoxic study
The platinum complex was submitted to in vitro cytotoxic anal-
yses using HeLa cells. The complex K2[PtCl2(ace)2] shows very low
cytotoxic activity against HeLa cells when compared to the vehicle-
treated cells (Fig. 6). The complex was able to induce 15–20% of
total cell death only at the concentration of 200 lM, which is a
high concentration compared to other metal-based complexes.
Comparatively, IC50 for cisplatin, a classical metal-based antineo-
plastic drug, is about 15 lM (data not shown here).
3.5. Antimycobacterial activity
The Ag–ace complex showed a good antimycobacterial activity
against M. tuberculosis, the agent responsible for the tuberculosis
infection. The MIC value for this compound is 3.12 lM, which is
an interesting and promising result. This MIC value indicates that
the Ag–ace complex is more efﬁcient against M. tuberculosis than
the commercial compound Ag(I)-sulfadiazine (MIC 21.8 lM). The
Ag(I)–acesulfame complex is less active than isoniazid (MIC
0.22 lM), which is used as a ﬁrst line tuberculosis drug. However,
it is much more effective than ethambutol (MIC 14.4 lM) and
pirazinamide (MIC 203.0 lM), which have been used for tuberculo-
sis treatment [42].
3.6. Antibacterial activity
Antibiotic sensitivity proﬁles of bacterial strains are listed in
Table 7.
Table 6
Selected angles (deg) of the Ag–ace complex.
O(12)–Ag(2)–O(22) 168.82(8) S(1)–N(1)–Ag(1) 118.75(12)
O(12)–Ag(2)–O(211)#1 97.95(7) C(24)–N(2)–S(2) 117.18(19)
O(22)–Ag(2)–O(211)#1 89.88(7) C(24)–N(2)–Ag(1) 127.31(18)
O(12)–Ag(2)–Ag(1) 83.83(6) S(2)–N(2)–Ag(1) 115.11(11)
O(22)–Ag(2)–Ag(1) 85.91(5) C(13)–C(11)–O(11) 120.7(3)
O(211)#1–Ag(2)–Ag(1) 157.67(5) C(13)–C(11)–C(12) 127.2(3)
N(2)–Ag(1)–N(1) 158.52(8) O(11)–C(11)–C(12) 112.0(3)
N(2)–Ag(1)–O(1W) 108.84(6) C(11)–C(13)–C(14) 122.7(3)
N(1)–Ag(1)–O(1W) 91.32(7) O(12)–C(14)–N(1) 121.7(3)
N(2)–Ag(1)–O(212)#2 89.95(7) O(12)–C(14)–C(13) 117.9(3)
N(1)–Ag(1)–O(212)#2 99.75(8) N(1)–C(14)–C(13) 120.3(2)
O(1W)–Ag(1)–O(212)#2 83.99(7) C(21)–C(23)–C(24) 123.3(3)
N(2)–Ag(1)–Ag(2) 78.96(6) O(22)–C(24)–N(2) 120.8(3)
N(1)–Ag(1)–Ag(2) 80.29(6) O(22)–C(24)–C(23) 118.2(2)
O(1W)–Ag(1)–Ag(2) 144.21(5) N(2)–C(24)–C(23) 121.0(2)
O(212)#2–Ag(1)–Ag(2) 131.62(5) C(21)–O(21)–S(2) 116.38(18)
O(111)–S(1)–O(112) 118.24(15) C(23)–C(21)–O(21) 119.8(3)
O(111)–S(1)–N(1) 110.50(13) C(23)–C(21)–C(22) 128.0(3)
O(112)–S(1)–N(1) 112.57(13) O(21)–C(21)–C(22) 112.2(3)
O(111)–S(1)–O(11) 104.29(13) O(212)–S(2)–O(211) 117.79(13)
O(112)–S(1)–O(11) 105.63(13) O(212)–S(2)–N(2) 111.67(13)
N(1)–S(1)–O(11) 104.12(12) O(211)–S(2)–N(2) 109.69(12)
Ag(1)–O(1W)–Ag(1)#3 94.72(10) O(212)–S(2)–O(21) 106.60(13)
C(11)–O(11)–S(1) 116.01(18) O(211)–S(2)–O(21) 104.55(13)
C(14)–O(12)–Ag(2) 127.7(2) N(2)–S(2)–O(21) 105.53(12)
C(24)–O(22)–Ag(2) 126.95(18) S(2)–O(211)–Ag(2)#4 125.42(13)
C(14)–N(1)–S(1) 116.6(2) S(2)–O(212)–Ag(1)#2 144.72(14)
C(14)–N(1)–Ag(1) 123.86(18)
Symmetry transformations used to generate equivalent atoms: #1 x, y + 1, z #2
x + 1, y1, z #3 x + 3/2, y, z + 1/2 #4 x, y1, z.
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Fig. 4. Thermogravimetric curve of the Pt(II)–acesulfame complex, under the
following conditions: synthetic air at 100 mL/min, and heating at 10 K/min, from 30
to 1000 C. Inset: XRD patterns of the residue at 650 C and 1200 C. Standard
reﬂections of platinum(0) and potassium sulfate were also included.
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Fig. 6. Percent cell death for the control and the Pt–ace complex after 18–24 h
following different doses of drug against HeLa cells.
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According to the literature, Ag(I) ions have shown to be highly
reactive, binding to tissue proteins and leading to structural
changes in the bacterial cell wall [43]. Silver also binds to bacterial
DNA and RNA leading to inhibition of bacterial replication [43,44].
Indeed, promising results about the bactericidal activity of silver
nanoparticles have been recently described in the literature
[45,46].
The results show a good antibacterial activity for Ag–ace against
Gram negative (E. coli and P. aeruginosa) and Gram positive (E. fae-
calis) microorganisms, as observed by the disc diffusion method. It
was found that impregnated ﬁlter discs with the Ag–ace complex
exhibit inhibition zones for E. coli, P. aeruginosa and E. faecalis of
14 mm, 18 mm and 14 mm, respectively, being similar to the anti-
microbial activity exhibited by AgNO3. The Ag–ace complex
showed a low antimicrobial activity against S. aureus since a dis-
crete bacterial growth was observed around the disc impregnated
with the complex. The Pt–ace complex did not show antimicrobial
activity against the tested microorganisms.
3.7. Antiviral activity
Dengue fever is an infectious disease that occurs in tropical and
subtropical regions caused by dengue virus (DENV). It is estimated
that 50–100 million persons are infected by dengue annually and
no vaccine and clinically useful antiviral drugs were discovered
up to the present time. Quantitative replication proﬁle of dengue
virus type 2 (New Guinea C strain) in Vero cells for different doses
of the Pt–ace complex was evaluated as shown in Fig. 7. The Pt–ace
complex shows a good inhibition of virus replication mainly at
200 lM when compared to the vehicle-treated cells. The com-
pound showed no evidence of toxicity to the cells over the concen-
tration ranges tested. Therefore, the preliminary antiviral potency
showed by the Pt–ace complex encourages further investigations
to elucidate in which step of the viral life cycle the inhibition
occurs.
4. Abbreviations
ace acesulfame (or, potassium salt of 6-methyl-1,2,3-oxathia-
zin-4 (3H)-one-2,2-dioxide)
IR infrared
s strong
sh shoulder
m medium
w weak
PBS phosphate-buffered saline
DMEM Dulbecco’s modiﬁed Eagle’s medium
FCS fetal calf serum
ATCC American type cell collection
BHI brain–heart infusion
CFU colony-forming unit
OADC oleic acid, albumin, dextrose, and catalase
MTT methylthiazol tetrazolium
FBS fetal bovine serum
TG thermogravimetry
DTA differential thermal analysis
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